325 related articles for article (PubMed ID: 16875900)
41. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
McCall KL; Craddock D; Edwards K
Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
[TBL] [Abstract][Full Text] [Related]
42. [The role of ACE inhibitors and angiotensin receptor blockers in the treatment and prevention of chronic heart failure].
Kárpáti P
Orv Hetil; 2005 May; 146(18):827-31. PubMed ID: 15926627
[TBL] [Abstract][Full Text] [Related]
43. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
[TBL] [Abstract][Full Text] [Related]
44. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
45. Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis.
Li TJ; Zang WD; Chen YL; Geng N; Ma SM; Li XD
Int J Clin Pract; 2013 Jun; 67(6):536-43. PubMed ID: 23557493
[TBL] [Abstract][Full Text] [Related]
46. Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting.
Johnston K; Stephens S
Ann Pharmacother; 2012 Sep; 46(9):1239-44. PubMed ID: 22947592
[TBL] [Abstract][Full Text] [Related]
47. The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.
Mayson SE; Greenspon AJ; Adams S; Decaro MV; Sheth M; Weitz HH; Whellan DJ
Cardiol Rev; 2007; 15(5):231-41. PubMed ID: 17700382
[TBL] [Abstract][Full Text] [Related]
48. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
[TBL] [Abstract][Full Text] [Related]
49. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
[TBL] [Abstract][Full Text] [Related]
50. Renin-angiotensin system mediators and Raynaud's phenomenon.
Wood HM; Ernst ME
Ann Pharmacother; 2006 Nov; 40(11):1998-2002. PubMed ID: 17003081
[TBL] [Abstract][Full Text] [Related]
51. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
Elahi MM; Flatman S; Matata BM
Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
[TBL] [Abstract][Full Text] [Related]
52. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study.
Etminan M; Zhang B; Fitzgerald M; Brophy JM
Pharmacotherapy; 2006 Apr; 26(4):479-82. PubMed ID: 16553505
[TBL] [Abstract][Full Text] [Related]
53. Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure.
Scow DT; Smith EG; Shaughnessy AF
Am Fam Physician; 2003 Nov; 68(9):1795-8. PubMed ID: 14620599
[TBL] [Abstract][Full Text] [Related]
54. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
Dai SM; Zhang S; Chu JM; Guo YH; Chen KP; Yao Sy
Med Hypotheses; 2007; 69(4):767-72. PubMed ID: 17475415
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin II receptor blockers in the prevention of atrial fibrillation.
Barra S; Silvestri N; Vitagliano G; Madrid A; Gaeta G
Expert Opin Pharmacother; 2009 Jun; 10(9):1395-411. PubMed ID: 19466911
[TBL] [Abstract][Full Text] [Related]
56. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.
Khatib R; Joseph P; Briel M; Yusuf S; Healey J
Int J Cardiol; 2013 Apr; 165(1):17-24. PubMed ID: 22421406
[TBL] [Abstract][Full Text] [Related]
57. Inhibiting the renin-angiotensin system: why and in which patients.
Berra K; Miller NH
J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
[TBL] [Abstract][Full Text] [Related]
58. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations.
Tavakol M; Hassan KZ; Abdula RK; Briggs W; Oribabor CE; Tortolani AJ; Sacchi TJ; Lee LY; Heitner JF
Ann Thorac Surg; 2009 Sep; 88(3):802-7. PubMed ID: 19699901
[TBL] [Abstract][Full Text] [Related]
59. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
Healey JS; Baranchuk A; Crystal E; Morillo CA; Garfinkle M; Yusuf S; Connolly SJ
J Am Coll Cardiol; 2005 Jun; 45(11):1832-9. PubMed ID: 15936615
[TBL] [Abstract][Full Text] [Related]
60. Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis.
Jibrini MB; Molnar J; Arora RR
Am J Ther; 2008; 15(1):36-43. PubMed ID: 18223352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
